Collard Craig A bought HRTX

April 3, 2024 · Form 4 insider transaction

Collard Craig A bought 62,500 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

62,500

Price

N/A

Total value

N/A

InsiderCollard Craig A

RoleOfficer, Director

CompanyHeron Therapeutics, Inc. (HRTX)

SecurityCommon Stock

Transaction codeM — Option exercise

Transaction dateApril 3, 2024

Filing dateApril 5, 2024

Shares owned after248,996

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock.

View the original Form 4 on SEC EDGAR